Autophagy is an evolutionarily conserved catabolic process that recycles nutrients upon starvation and maintains cellular energy homeostasis 1-3 . Its acute regulation by nutrient-sensing signalling pathways is well described, but its longer-term transcriptional regulation is not. The nuclear receptors peroxisome proliferator-activated receptor-a (PPARa) and farnesoid X receptor (FXR) are activated in the fasted and fed liver, respectively 4,5 . Here we show that both PPARa and FXR regulate hepatic autophagy in mice. Pharmacological activation of PPARa reverses the normal suppression of autophagy in the fed state, inducing autophagic lipid degradation, or lipophagy. This response is lost in PPARa knockout (Ppara 2/2 , also known as Nr1c1 2/2 ) mice, which are partially defective in the induction of autophagy by fasting. Pharmacological activation of the bile acid receptor FXR strongly suppresses the induction of autophagy in the fasting state, and this response is absent in FXR knockout (Fxr 2/2 , also known as Nr1h4 2/2 ) mice, which show a partial defect in suppression of hepatic autophagy in the fed state. PPARa and FXR compete for binding to shared sites in autophagic gene promoters, with opposite transcriptional outputs. These results reveal complementary, interlocking mechanisms for regulation of autophagy by nutrient status.
and initially tested the effect of their pharmacological activation in the mouse hepatocyte cell line AML12 expressing a triple fusion protein of monomeric red fluorescent protein (mRFP), green fluorescent protein (GFP) and the autophagosome marker LC3 (mRFP-GFP-LC3) [14] [15] [16] . In autophagosomes, the combination of both RFP and GFP in the triple fusion yields yellow fluorescence, whereas autolysosomal delivery results in red. As expected, the yellow fluorescence in normally cultured cells was converted to red by acute nutrient deprivation ( Fig. 1 and Extended Data Fig. 1f ). The FXR agonist GW4064 (ref. 17) prevented this process in the nutrient-deprived cells, whereas the PPARa agonist GW7647 (ref. 18 ) mimicked it in non-starved cells ( Fig. 1a and Extended Data Fig. 1f ). Extensive cell-based studies of levels of LC3 conjugated to phosphatidylethanolamine (LC3-II) and other indicators of autophagy confirmed that these responses are dose and time dependent, and indicated that they are not dependent on altered mammalian target of rapamycin complex 1 (mTORC1) activity, but are associated with a decrease in the inhibitory phosphorylation of ULK1 (ref. 19 ) in response to PPARa activation, and an increase in response to FXR activation (Fig. 1b, c and Extended Data Fig. 2a-d) . Indeed, GW7647 induces autophagic flux even in nonstarved cells, whereas GW4064 suppresses it even in starved cells, or cells treated with the mTOR inhibitor Torin1 (ref. 20) (Extended Data Fig. 1a-e ). Activation of FXR by bile acids also suppresses LC3-II induction (Extended Data Fig. 2c ).
In livers of chow-fed or fasted wild-type C57BL/6J mice, LC3-II levels were increased in the fasted state ( Fig. 2a, b and Extended Data Fig. 2e ), and messenger RNA expression of LC3a (also known as Map1lc3a) and other autophagic genes was also induced (Extended Data Figs 2f and 3a-c). PPARa agonist treatment strongly increased levels of both nonlipidated LC3 (LC3-I) and LC3-II in the fed state in wild-type but not Ppara 2/2 mice 21 , and both were further increased in the fasted state ( Fig. 2a and Extended Data Fig. 3b ). GW7647 also induced LC3a mRNA expression in the fed and fasted states, and these responses were lost in Ppara 2/2 mice (Extended Data Fig. 3a ). 1 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA. 2 In fed or fasted mice treated with the FXR agonist, induction of LC3-II protein in the fasted state was suppressed in wild-type, but not Fxr 2/2 livers ( Fig. 2b and Extended Data Fig. 3d ). LC3-II levels were unaffected by GW4064 in fed and fasted Fxr 2/2 mice 22 (Fig. 2b) . At the mRNA level, GW4064 completely suppressed the induction of LC3b in the fasted state (Extended Data Fig. 3c ). As expected, GW4064 treatment also suppressed CYP7A1, but induced SHP expression in both the fasted and fed states in wild-type, but not Fxr 2/2 mice (Extended Data Figs 2g and 3c).
These results were confirmed using GFP-LC3 transgenic mice (GFP-LC3 Tg/1 ) 15, 16, 23 and GFP-LC3 Tg/1 plus Ppara 2/2 or Fxr 2/2 double mutants. Green puncta indicating autophagosome formation were increased in fasted GFP-LC3 Tg/1 mice (Fig. 2c ). The PPARa agonist also significantly increased puncta in the fed GFP-LC3 Tg/1 mice, but not in the Ppara 2/2 GFP-LC3 Tg/1 double mutants ( Fig. 2c and Extended Data Fig. 3e ). In the opposite direction, the FXR agonist strongly suppressed induction of puncta in the fasted GFP-LC3 Tg/1 mice, but not in the fed state, and had no effect in the Fxr 2/2 GFP-LC3 Tg/1 double mutants ( Fig. 2c and Extended Data Fig. 3e ). The induction of puncta by fasting was significantly lower in the Ppara 2/2 GFP-LC3 Tg/1 double mutants, whereas their number in the fed state was significantly increased in the Fxr 2/2 GFP-LC3 Tg/1 mutants ( Fig. 2c and Extended Data Fig. 3e ). These partially defective responses in the double mutants demonstrate that PPARa is required for the full induction of autophagy by fasting, and FXR is required for its full suppression by feeding.
In agonist-or vehicle-treated fed and fasted livers, quantification of autophagic vesicles by transmission electron microscopy confirmed an increase in response to GW7647 in the fed state, and a strong decrease in response to GW4064 in the fasted state ( Fig. 3a) . Moreover, fasted livers of Ppara 2/2 mice show compromised formation of autophagic vesicles but increased numbers and size of lipid droplets. Conversely, livers of fed Fxr 2/2 mice show enhanced formation of autophagic vesicles (Extended Data Fig. 4a, c) . Autophagosomes induced by the PPARa agonist frequently contained lipid droplets, suggesting an increase in lipophagy consistent with the role of this receptor in fatty acid oxidation (Extended Data Fig. 4b ). This was confirmed in AML12 cells treated with or without oleate to induce lipid droplet formation, and then either starved or not and also treated with vehicle, the PPARa agonist Wy-14,643 or GW4064. Visualization of LC3 (red) revealed colocalization with lipid droplets labelled with the fluorophore dipyrromethene boron difluoride (BODIPY 493/503; green) in the starved cells, as expected, and also in the non-fasted, Wy-14,643-treated cells ( Fig. 3b and Extended Data Fig. 3f ). In accord with a functional role for the induction of lipophagy, specific knockdown of either Atg5 or Atg7 significantly blunted the increase in fatty acid oxidation in response to Wy-14,643 in basal and oleate-treated AML12 cells, as indicated by ketone body production (Extended Data Fig. 3g ). Similarly, both fasting and GW7647 induced serum b-hydroxybutryate levels in control homozygous floxed Atg7 (Atg7 F/F ) mice 24 , and both responses were decreased in liver specific Atg7 knockouts (Extended Data Fig. 3h ).
Direct transcriptional effects are the most likely explanation for the effect of both PPARa and FXR on autophagy. Initial results confirmed that total LC3 protein levels are increased and decreased in response to fasting and refeeding, and mRNA expression of LC3a and LC3b (also known as Map1lc3b) and several other autophagic genes is increased in the fasted state and decreased in the refed state (Extended Data Fig. 2e , f). Among a core panel of 63 autophagy-related genes ( Supplementary  Table 1 ), 13 were both induced by GW7647 and repressed by GW4064 in wild-type mice, with both responses lost in relevant knockout mice ( Fig. 4a and Extended data Fig. 5c ), 11 more were responsive only to GW7647, whereas 4 responded only to GW4064 (Extended Data Fig. 5a , b).
To define the basis for PPARa induction of autophagy-related genes, we determined the mouse liver PPARa cistrome with or without GW7647. The most significantly enriched binding motif among identified peaks was the known PPARa-retinoid X receptor (RXR)-binding site (direct repeat 1, or DR1), as expected, and nearly all of the peaks were absent in the Ppara 2/2 cistromes (Extended Data Figs 6a and 7a). PPARabinding sites on core autophagy machinery gene loci as well as many regulatory and effector genes were confirmed by standard PPARa chromatin . Many of the peaks on these genes (Extended Data Fig. 7a ), and an additional panel of key autophagy components including Pink1, Optn, Vps11 and Becn1 ( Supplementary Fig. 1 ), were further enhanced by GW7647 treatment, demonstrating that PPARa agonist treatment not only generates new binding sites, but also further increases PPARa recruitment to specific target genes (Extended Data Fig. 6b ). The PPARa cistrome shows that at least 124 of an extended 230 autophagy-related gene list have at least one receptor binding peak within 20 kilobases (kb) from the transcription start site, while a FXR 25 cistrome shows 61 potential targets (Extended Data Fig. 6d ). A hypergeometric test confirmed that both are highly enriched relative to a random gene pool (Extended Data Fig. 6d ). Intriguingly, approximately 27% of agonist induced PPARa binding peaks overlapped with 72% of agonistinduced FXR binding peaks (Extended Data Fig. 6c ). Consistent with this, peaks for PPARa and FXR directly overlap at 41 out of the 230 extended autophagic target genes, as exemplified by LC3a ( Fig. 4b ) and
LC3b (Extended Data Fig. 8a ). This was unexpected, on the basis of their very different direct (PPAR, DR1) and inverted (FXR, inverted repeat 1 (IR1)) repeat consensus binding sites. However, FXR has also been reported to bind DR1 sites in the Apoc3 (ref. 26) and Apoa (ref. 27) promoters, where it acts as a ligand-dependent transcriptional repressor, raising the prospect that it could repress autophagic gene expression via a similar mechanism.
Quantitative assessment confirmed that GW7646 treatment increased PPARa binding to peaks containing a single DR1 site in the LC3a and LC3b enhancers ( Fig. 4c ) and the Acox1 promoter (Extended Data Fig. 8a, b ), and increased RNA polymerase II recruitment to the genes. Thus, in the fed state, the increased PPARa binding was able to overcome the relatively silent chromatin state and decrease FXR occupancy for the LC3a and Acox1 DR1 sites. In the opposite direction, GW4064 did not have much effect on the already silent chromatin in the fed state, in accord with the functional studies (Figs 2 and 3 ). In the transcriptionally active fasted state, however, the FXR agonist significantly increased FXR binding, decreased RNA polymerase II recruitment, and also decreased PPARa binding to all three elements ( Fig. 4c and Extended Data Fig. 8b ). Overall, these results closely match the functional results and indicate that pharmacological activation of each nutrient-sensing nuclear receptor can overcome the chromatin state imposed by the opposite nutrient signal (fed for PPARa and fasted for FXR). They also indicate that PPARa and FXR compete for binding to single sites in some chromatin states.
To test this, we focused on the DR1 motifs in the regulatory region of the LC3a and LC3b genes. Cell-based reporter assays with promoter constructs including only the DR1 motifs confirmed the opposite responses, with the PPARa agonist further inducing, and the FXR agonist suppressing luciferase expression relative to the increased basal transactivation observed with both PPARa and FXR alone (Extended Data Fig. 8d ).
In the presence of both receptors, GW4064 suppressed both basal and Wy-14,643-induced expression. Similar results were also observed using a conventional PPAR response element (PPRE) luciferase reporter construct (33PPRE-luc) (Extended Data Fig. 8c ). Mutation of the LC3a or LC3b DR1 elements blocked all responses to PPARa, as expected, but only diminished the responses to FXR (Extended Data Fig. 8d ). The basis 
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for this residual response, which cannot be correlated with direct FXR or FXR-RXR binding in vitro, is unclear. The ability of GW4064 to inhibit PPARa-dependent transactivation of the LC3b DR1 motif is dependent on corepressors, because it was blocked by short interfering RNA (siRNA) knockdown of either SMRT or SHP (Extended Data Fig. 8e ). Consistent with these functional results, GW7647 treatment increased p300 coactivator recruitment to the DR1 region of LC3a and LC3b enhancers and increased histone H4 acetylation, an active chromatin mark. By contrast, GW4064 treatment increased binding of the corepressors NCoR and SMRT, and increased levels of the repressive histone H3 trimethyl Lys 27 (H3K27me3) mark at the same DR1 regulatory region, particularly in the fasted state (Extended Data Fig. 9 ). Overall, we conclude that PPARa and FXR directly compete for binding to the same DR1 elements at autophagic, and probably additional promoters, with opposite transcriptional outputs. This mechanism is distinct from, but complementary to, the inhibition of CRTC2 recruitment described in the accompanying manuscript 28 . Thus, CRTC2 was not significantly recruited to the LC3a DR1 enhancer, as expected, but we confirmed the ability of GW4064 treatment to decrease CRTC2 occupancy to its proximal promoter site in the fasted state (Extended Data Fig. 10a) .
These results define new mechanisms for regulation of autophagy by nutrient-sensing nuclear receptors (Extended Data Fig. 10b ). Pharmacological activation of either PPARa or FXR robustly affects hepatic autophagy. GW7467 activates it even in the fed state, which is associated with an increase in lipophagy. GW4064 potently suppresses the process in the fasted state. The significantly blunted autophagic responses of PPARa and FXR knockouts to fasting or feeding, respectively, strongly confirm the physiological relevance of the pharmacologically defined responses.
Both nuclear receptors directly induce or repress extensive panels of autophagy-related genes in accord with the overall responses. However, the effect of the synthetic agonists seems greater than the magnitude of the transcriptional responses, suggesting a role for less direct effects. We did not observe effects on mTOR, the dominant upstream regulator of autophagy. However, there were alterations in the inhibitory phosphorylation of ULK1(Ser 757) that would be consistent with such effects. In addition, induction of the transcriptional repressor SHP is a welldescribed mechanism for FXR-dependent suppression of genes of bile acid biosynthesis 29, 30 . However, preliminary results indicate that the suppressive effects of GW4064 are maintained in Shp 2/2 (also known as Nr0b2 2/2 ) mice (data not shown).
These results reveal intersecting and complementary genomic circuits in which PPARa and FXR induce and suppress hepatic autophagy, respectively (Extended Data Fig. 10b ). They further integrate autophagy, which is often associated with more extreme nutrient stresses, with more physiological nutrient responses. They also establish PPARa and FXR as potential targets for therapeutic modulation autophagy, which may be useful for liver or other metabolic tissues and could affect the pathogenesis of a wide range of human diseases. Author Information PPARa ChIP-seq data sets have been deposited in the NCBI Gene Expression Omnibus with the accession number GSE61817. Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests. Readers are welcome to comment on the online version of the paper. Correspondence and requests for materials should be addressed to D.D.M. (moore@bcm.edu).
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METHODS
Materials. C57BL/6J and Ppara 2/2 mice were from the Jackson Laboratory; Fxr 2/2 and GFP-LC3 transgenic mice were previously described 23 . Antibodies to LC3 (NB600-1384) were from Novus Biologicals; rabbit antibodies to phosphorylated Ser 240/244 S6 (5364), S6 (2217), phosphorylated Thr 37/46-4E-BP1 (2855), 4E-BP1 (9452), anti-mouse IgG-horseradish peroxidise (HRP) (7076) and b-actin (5125) were from Cell Signaling Technology; antibodies to normal rabbit IgG (sc-2027), PPARa (sc-9000x), FXR (sc-13063x), Pol II (sc-899x), p300 (sc-585x), CRTC2/ TORC2 (sc-6714x) and anti-rabbit IgG-HRP (sc-2370) were from Santa Cruz Biotechnology; antibody to histone H3K27me3 (39155) was from ACTIVE MOTIF. GW7647 and Wy-14,643 were from Cayman chemicals; GW4064 was from Tocris bioscience; bafilomycin A 1 was from Enzo Life Science; AML12 cells were from ATCC (CRL-2254). GFP antibody (11814460001), PhosSTOP (04906837001) and complete protease cocktail (11836170001) were from Roche; insulin-transferrinselenium (ITS) (41400-045), lipofectamine 2000 (11668019), BODIPY 493/503 (D-3922), Alexa Fluor 594 goat anti-rabbit IgG (A11037), Stealth siRNAs-NCoR (NcoR1, MSS208758), SMRT (NcoR2, MSS20912), SHP (NR0b2, MSS239500) and HIGH_GC were from Invitrogen. The mRFP-GFP-LC3(ptfLC3) plasmid was a gift from T. Yoshimori (Addgene plasmid 21074). Anti-rabbit p62/SQSTM1 (P0067), anti-rabbit LC3B (L7543), oleic-acid-albumin (O3008-5ML) and dexamethasone (D4902-25MG) were from Sigma. Protein A Sepharose CL-48 (17-0780-01) was from GE Healthcare; VECTASHIELD (H-1200) was from Vector Laboratories; SacI-HF (R3156S) and BglII (R0144S) were from New England Biolabs. Pierce BCA Protein Assay Kit (23227) was from Thermo Scientific; SMRT antibody (ab24551) and b-hydroxybutyrate assay kit (ab83390) were from abcam. Anti-acetyl-histone H4 antibody (06-866) was from EMD Millipore. Polyclonal rabbit antibody against NCoR was as described 33 . Other reagent information not shown here is described in the relevant methods and references. Animal studies. All animal studies and procedures were approved by the institutional Animal Care and Use Committee of the Baylor College of Medicine. Male GFP-LC3 Tg/1 mice were bred with either female Ppara 2/2 or Fxr 2/2 mice to generate bigenic Ppara 2/2 GFP-LC3 Tg/1 or Fxr 2/2 GFP-LC3 Tg/1 mice. Ppara 2/2 and Fxr 2/2 mice were pure C57BL/6 background. C57BL/6J mice were wild-type controls. Eight-to-ten-week-old male wild-type C57BL/6J, Ppara 2/2 , Fxr 2/2 , GFP-LC3 Tg/1 , Ppara 2/2 GFP-LC3 Tg/1 or Fxr 2/2 GFP-LC3 Tg/1 mice were orally gavaged with vehicle (dimethylsulphoxide (DMSO) in 4:1 of PEG-400 and Tween 80), GW7647 (5 mg kg 21 body weight) or GW4064 (100 mg kg 21 body weight) twice a day (first injection: 00:00, second injection: 12:00). Mice were fed ad libitum or fasted for 24 h from 18:00 (day 1) to 18:00 (day 2) and then scarified to collect blood and livers. Collected liver tissues were immediately frozen in liquid nitrogen for molecular studies. The refed condition was 24 h fasted mice followed by feeding those mice with normal chow diets for another 24 h. To avoid circadian issues, all mice were scarified at 17:00-18:00. GFP-LC3 Tg/1 mice were a gift from N. Mizushima. Primary hepatocyte culture. Eight-to-ten-week-old male GFP-LC3 Tg/1 mice were anesthetized with Avertin (Sigma Aldrich, T48402, 240 mg kg 21 body weight) by intraperitoneal (i.p.) injection. The liver perfusions were done by injecting butterfly needle into the portal vein and providing the following solutions sequentially: 50 ml EBSS (ATLANTA biologicals, B31350) supplemented with 10 mM HEPES (Invitrogen, 24020-117) and 0.5 mM EGTA and then 50 ml of HBSS supplemented with 100 U ml 21 of collagenase IV (Invitrogen, 17101-015), and 0.05 mg ml 21 of trypsin inhibitor (Invitrogen, 17075-029). The perfused liver was carefully taken out, put onto a Petri dish with 25 ml of hepatocyte wash media added (Invitrogen, 17704-024), and massaged with two cell scrapers until the liver came apart with only connective tissue left behind. Dissociated cells were passed through a mesh funnel into a 50 ml falcon tube. After centrifugation at 600 r.p.m. for 2 min, the cell pellet was resuspended in hepatocyte wash media consisting of carefully overlaid Percoll solution (final 40%) pre-mixed with 150 mM NaCl. After centrifugation at 600 r.p.m. for 10 min, the collected cell pellet was washed twice with hepatocyte wash media, and then suspended in Williams' E medium (Invitrogen, 12551-032) supplemented with 10% FBS, 1% penicillin/streptomycin, ITS and glutaMAX (Invitrogen, 35050-061). All drug treatments or starvation experiments were performed 4-6 h after the initial plating on the culture dishes. Cell culture and transfection. AML12 cells were maintained in the following media: (normal) DMEM/F12 high glucose (Invitrogen, 11330-057) supplemented with 10% FBS, 1% ITS, 1% penicillin/streptomycin antibiotics and 40 ng ml 21 dexamethasone; (starvation) HBSS media with Ca 21 and Mg 21 supplemented with 10 mM HEPES (Invitrogen, 15630). mRFP-GFP-LC3 plasmids were transfected into AML12 cells grown on Lab-tek II Chamber Slide (Nunc, 154461) with Lipofectamine 2000 according to the manufacturer's protocol for 24 h followed by drug treatments for 24 h. Transfected cells were starved for 2 h, and then washed three times with cold PBS, fixed with 3% paraformaldehyde (PFA) in PBS for 10 min at room temperature, and washed three times with PBS. Cells were counterstained with mounting solution containing DAPI. All drugs were dissolved in DMSO. Vehicle: complete media containing 0.1% DMSO. Starvation: HBSS media with 10 mM HEPES. Autophagic fluxes were quantified as follows: autolysosomes 5 RFP-positive vesicles -GFPpositive vesicles. Numbers of autolysosomes induced by 2 h starvation plus vehicle were set as 100%. BODIPY and immunofluorescence assay in cells. AML12 cells were plated on two-chamber Lab-tek II dishes at 30-50% confluent cells per chamber. The next day, cells were treated with vehicle (0.1% DMSO), 10 mM Wy-14,643 or 1 mM GW4064 in complete medium with or without 125 mM oleate for 24 h. Vehicle or GW4064treated cells were starved for 2 h in HBSS medium before fixation of cells. Cells were washed twice with PBS followed by fixation with 3% PFA for 20 min at room temperature. After fixation, cells were washed four times with PBS followed by incubation with blocking buffer (1.5 g glycine, 3 g BSA and 2 ml 0.5% (w/v) saponin in 100 ml PBS) for 45 min. Cells were incubated with rabbit anti-LC3b antibody (1:400 dilution in antibody diluent: 100 mg BSA, 2 ml 0.5% saponin in 100 ml PBS) overnight at 4 uC. Cells were washed four times (10 min each) with PBS followed by incubation with the secondary antibody (Alexa Fluor 594 goat anti-rabbit IgG, 1:200 dilution in antibody diluent) and BODIPY 493/503 (1 mg ml 21 concentration) for 1 h at room temperature. After that, cells were washed four times with PBS followed by DAPI staining with mounting solution. Cell images were obtained using a confocal microscope (NIKON A1Rsi dual scanner). Orange and yellow dots were defined as a lipophagic vacuole, which was quantified in at least in 30 cells per condition using ImageJ software. RNA purification and qPCR analysis. Total RNA was isolated from snap-frozen liver tissues using Trizol Reagent (Invitrogen, 15596-026) and prepared for the complementary DNA using QuantiTect reverse transcription kit (Qiagen, 205311). Hepatic gene expression was determined by qPCR using FastStart SYBR Green master (ROX) (Roche, 04673484001). mRNA levels were normalized by the 36B4 (also known as Rplp0) gene. qPCR primer information for autophagy-related genes is listed in Supplementary Table 1 , and all other primers were purchased from Qiagen. Immunoblot analysis. Cells cultured in 10-cm dishes were solubilized in 150 ml of RIPA buffer (25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS and 1 mM EDTA) supplemented with protease and phosphatase inhibitors. Liver tissues (50 mg) were homogenized in 1 ml RIPA buffer supplemented with protease and phosphatase inhibitors, followed by brief sonication. Protein concentration was determined using Pierce BCA Protein Assay Kit. Total proteins (25-50 mg) were loaded on either 12% or 4-20% Mini-PROTEAN TGX Precast Gel (Bio-rad, 456-1043 or 456-1093), transferred onto Immuno-Blot PVDF (polyvinylidene difluoride) membrane (Bio-rad, 162-0177) and analysed by immunoblot analysis using the ECL solution (Thermo Scientific, 34086, or Millipore, WBKLS0500). Histology and immunofluorescence. Liver tissues were collected and fixed in 4% PFA in PBS overnight at 4 uC. The tissues were treated with 15% sucrose in PBS at 4 uC for at least 4 h and then with 30% sucrose in PBS at 4 uC for overnight. Tissue samples were embedded in Tissue-Tek OCT (Sakura Finetek, 4583) and stored at 270 uC. The samples were sectioned at 5-7 mm thickness, air-dried for 30 min, and stored at 220 uC until use (Comparative Pathology Laboratory at Baylor College of Medicine). Images were taken on a confocal microscope (NIKON A1Rsi dual scanner). GFP-LC3 puncta were quantified in three independent visual fields from at least three independent mice using ImageJ software. ChIP assays. ChIP from mouse livers was performed as described previously 34 . For PPARa ChIP-seq and ChIP-qPCR (Extended Data Fig. 7) , livers were collected from fed wild-type or Ppara 2/2 mice treated with vehicle or GW7647 (5 mg kg 21 , twice a day, n 5 4 per group) after euthanasia. For PPARa, FXR, Pol II, p300, CRTC2 (TORC2), NCoR, SMRT, acetyl H4 and H3K27me3 ChIPs ( Fig. 4c and Extended Data Figs 9 and 10a ), fed or fasted wild-type mice were treated with vehicle, GW7647 (5 mg kg 21 ) or GW4064 (100 mg kg 21 ) twice a day (n 5 3 per group). Liver tissues (100 mg) were quickly minced using mortar and pestle with liquid nitrogen and cross-linked in 10 ml 1% formaldehyde/PBS for 15 min at room temperature, followed by quenching with 1/20 volume of 2.5 M glycine solution for 5 min. Minced liver tissues were washes twice with cold PBS (150 g, 5 min, 4 uC). Nuclear extracts were prepared by Dounce homogenization (30 strokes on ice, tight fitting pestletype B) in cell lysis buffer (5 mM PIPES, 85 mM KCl, 0.5% Igepal and complete protease inhibitor tablet from Roche, pH 8.0). Chromatin fragmentation was performed by sonication in 300 ml ChIP SDS lysis buffer (50 mM HEPES, 1% SDS, 10 mM EDTA, pH 7.5), using the Bioruptor (Diagenode, 4 3 5 min, 30 s on/30 s off). Proteins of interest were immunoprecipitated in ChIP dilution buffer (50 mM HEPES, 155 mM NaCl, 1.1% Triton X-100, 0.11% sodium deoxycholate, 1 mM phenylmethylsulphonyl fluoride (PMSF) and complete protease inhibitors tablet, pH 7.5) using 5 ml of each antibody. Cross-linking was reversed overnight at 65 uC, and DNA was isolated using phenol/chloroform/isoamyl alcohol. Precipitated DNA was analysed by qPCR. Primer sequences used for ChIP-qPCR analysis are listed in Supplementary Table 2 .
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PPARa ChIP-seq. For ChIP, frozen liver tissues were ground in liquid nitrogen and cross-linked in 1% formaldehyde for 20 min, followed by quenching with 1/20 volume of 2.5 M glycine solution, and two washes with PBS. Cell lysis and chromatin fragmentation were performed by sonication in ChIP dilution buffer (50 mM HEPES, 155 mM NaCl, 1.1% Triton X-100, 1% SDS, 0.11% sodium deoxycholate, 1 mM EDTA, and complete protease inhibitors tablet, pH 7.5). PPARa proteins were immunoprecipitated using PPARa antibody, cross-linking was reversed overnight at 65 uC, and DNA was isolated using phenol/chloroform/isoamyl alcohol. Precipitated DNA was analysed by qPCR. ChIP was performed independently on liver samples from fed wild-type or Ppara 2/2 mice treated with vehicle or GW7647 (5 mg kg 21 , twice a day), and the precipitated DNA or input DNA samples were pooled. Ten nanograms of the pooled DNA was then amplified according to ChIP Sequencing Sample Preparation Guide provided by Illumina, using adaptor oligonucleotides and primers from Illumina, enzymes from New England Biolabs and the PCR Purification Kit and MinElute Kit from Qiagen. Deep sequencing was performed by the Functional Genomics Core (J. Schug and K. Kaestner) of the Penn Diabetes Endocrinology Research Center using the Illumina Genome Analyzer IIx, and sequences were obtained using the Solexa Analysis Pipeline. ChIP-seq data analysis. Solexa sequencing reads were mapped to reference genome mm9 using Bowtie 35 . Peak calling was performed with MACS14 using default settings 36 . Peak heights were normalized to the total number of uniquely mapped reads and displayed in UCSC genome browser 37 as the number of tags per 10 million tags. De novo motif analysis was performed with MEME 31 using 200-bp regions centred at the summit of each peak. To analyse the enrichment of autophagy-related genes near PPARa-binding sites, all genes containing a PPARa-binding site (with or without the PPARa motif DR1) within 20 kb from the transcription start site were compared with a list of autophagy-related genes 32, [38] [39] [40] [41] [42] [43] [44] (Supplementary Table 1) . P values were calculated with hypergeometric test. Transmission electron microscopy. Anaesthetized mice were perfused with PBS for 3 min, followed immediately by perfusion with 2% PFA plus 2.5% glutaraldehyde in 0.1 M Millonig's phosphate buffer, pH 7.4. Liver tissue was quickly removed and minced in a large drop of cold fixative, then transferred to vials of cold fix and fixed overnight in 4 uC. After washing three times in 0.1 M Millonig's phosphate buffer, the tissue was post-fixed at room temperature in 0.1 M Millonig's phosphate buffer containing 1% osmium tetroxide for 1 h. Post-fixation was followed by three rinses, 5 min each, of 0.1 M Millonig's phosphate buffer, after which all tissues were dehydrated through a gradient series of ethanol, beginning with two 10 min changes of 50% ethanol and ending with three 20 min changes of 100% ethanol from a freshly opened bottle. Liver tissue was en bloc stained with saturated uranyl acetate in 50% ethanol for 1 h during the 50% ethanol dehydration stage. After complete dehydration, the tissue was infiltrated over a period of 2 days with progressively concentrated mixtures of plastic resin and 100% ethanol. Infiltration continued until the tissue reached pure resin. The tissue was then given three changes of pure, freshly made Spurr's plastic resin 45 for 3 h each, after which the liver tissue was embedded in 00 BEEM capsules 46 and placed in a 68 uC oven overnight. Thin sections of approximately 70 nm were obtained using an RMC MT6000-XL ultramicrotome (RMC) and a Diatome Ultra45 diamond knife (DiATOME), and collected on 150 hex-mesh copper grids. The sections were counterstained with Reynold's lead citrate 47 for 4 min. Dry samples were examined on a Hitachi H7500 transmission electron microscope and images were captured using a Gatan US1000 digital camera with Digital Micrograph (Gatan, v1.82.366) software. Molecular cloning and cell-based luciferase reporter assay. The oligonucleotides encompassing three copies of DR1 motifs found in mouse LC3a or LC3b enhancer region were annealed and treated with Klenow. Purified DNAs were cloned into pTK-luc plasmid by a serial digesting with SacI and BglII. Successful cloning was confirmed by DNA sequencing analysis. Oligonucleotide sequences used for luciferase reporter assays are listed in Supplementary Table 3 . For the luciferase assay, AML12 cells were cultured in 24-well plates. Transient transfections were performed using Lipofectamine 2000. Cell were transfected with 200 ng of reporter constructs, 100 ng of cytomegalovirus-promoter (CMX)-mouse PPARa, or CMX-human FXR, and 50 ng of CMX-b-galactosidase. pCDNA3.1 was added to prepare the total DNA to 500 ng per well. After 4 h transfection, cells were treated with or vehicle (0.1% DMSO), 10 mM Wy-14,643 or 1 mM GW4064 in media containing charcoal-stripped serum for 20 h before performing luciferase and b-galactosidase assay. Luciferase activity was normalized with b-galactosidase activity. Normalized values from vehicletreated cells transfected with empty CMX plasmid were set as fold 1. Measurement of b-hydroxybutyrate. AML12 cells were transfected with siControl (ON-TARGETplus Control pool, D-001810-10-20), siAtg5 (ON-TARGETplus SMARTpool siRNA Atg5, L-064838-00-0010), or siAtg7 (ON-TARGETplus SMARTpool siRNA Atg7, L-049953-00-0010) according to manufacturer's instructions. siRNAs were purchased from Thermo Scientific Dharmacon. Twenty-four hours after transfection using Lipofectamine 2000, cells were treated with vehicle (0.1% DMSO) or Wy-14,643 (10 mM) in media containing charcoalstripped serum and 250 mM oleate for 48 h. Released b-hydroxybutyrate in the medium was measured using a b-hydroxybutyrate assay kit. Female Atg7 F/F mice 24 were bred with male Alb-Cre/1 mice to generate control littermates (Atg7 F/F ) and hepatocyte-specific Atg7-null (Alb-Cre/1 Atg7 F/F ) mice. Eight-week-old male Atg7 F/F and Alb-Cre/ 1 Atg7 F/F mice were orally gavaged with either vehicle (DMSO in 4:1 of PEG-400 and Tween 80) or GW7647 (5 mg kg 21 body weight) twice a day (first injection: 00:00, second injection: 12:00). Mice were fed ad libitum or fasted for 24 h from 18:00 (day 1) to 18:00 (day 2) and then scarified to collect blood and livers. Serum b-hydroxybutyrate concentrations were normalized with mouse liver weights. Statistical analysis. Sample size for experiments was determined empirically based on preliminary experiments to ensure appropriate statistical power. Age, sex and weight-matched mice were randomly assigned for the treatments. No animals were excluded from statistical analysis, and the investigators were not blinded in the studies. Values are expressed as mean 6 s.e.m., and error bars for all results were derived from biological replicates rather than technical replicates. Significant differences between two groups were evaluated using a two-tailed, unpaired t-test, which was found to be appropriate as groups displayed a normal distribution and comparable variance. P , 0.05 was considered statistically significant.
